Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream [Pramoson... — RxCUI 1234519
RxNorm drug concept · Semantic branded drug
RxCUI 1234519
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1234519
Official nameHydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream [Pramosone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPramosone (hydrocortisone acetate 1 % / pramoxine HCl 1 % ) Topical Cream
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
- What exactly is this enema treating — is it the same as regular colitis medicine?
- Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
- How long do I need to use it before it starts working?
🕸️ Concept Web — How Hydrocortisone acetate 10 MG/ML / pramoxine hydr... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream [Pramosone]
RxCUI 1234519 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Hydrocortisone
5492IN -
Pramoxine
34347IN -
Hydrocortisone / pramoxine
106955MIN -
Hydrocortisone acetate
27197PIN -
Pramoxine hydrochloride
57555PIN
-
Hydrocortisone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Pramosone
219334BN
-
Pramosone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydrocortisone / pramoxine Topical Cream
377721SCDF -
Hydrocortisone acetate / pramoxine hydrochloride Topical Cream
2645987SCDFP -
Hydrocortisone / pramoxine Topical Product
1164001SCDG -
Hydrocortisone acetate / pramoxine hydrochloride Topical Product
2662709SCDGP -
Hydrocortisone / pramoxine Topical Cream [Pramosone]
1234518SBDF -
Hydrocortisone acetate / pramoxine hydrochloride Topical Cream [Pramosone]
2658308SBDFP -
Pramosone Topical Product
1234321SBDG -
Topical Cream
316982DF - +1 more in this family
-
Hydrocortisone / pramoxine Topical Cream
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream
1116499SCD -
Hydrocortisone acetate 10 MG/ML
828360SCDC -
Pramoxine hydrochloride 10 MG/ML
828361SCDC -
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML [Pramosone]
1234394SBDC
-
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Cream
SCD · 1116499 -
Hydrocortisone acetate 10 MG/ML
SCDC · 828360 -
Pramoxine hydrochloride 10 MG/ML
SCDC · 828361 -
Hydrocortisone / pramoxine Topical Cream
SCDF · 377721 -
Hydrocortisone acetate / pramoxine hydrochloride Topical Cream
SCDFP · 2645987 -
Hydrocortisone / pramoxine Topical Product
SCDG · 1164001 -
Hydrocortisone acetate / pramoxine hydrochloride Topical Product
SCDGP · 2662709
Brand-Name Concepts
-
Hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML [Pramosone]
SBDC · 1234394 -
Hydrocortisone / pramoxine Topical Cream [Pramosone]
SBDF · 1234518 -
Hydrocortisone acetate / pramoxine hydrochloride Topical Cream [Pramosone]
SBDFP · 2658308 -
Pramosone Topical Product
SBDG · 1234321 -
Pramosone
BN · 219334
📦 FDA Products & Package NDCs
3 products · 4 package NDCs
4 package NDCs map to RxCUI 1234519 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 54766-0716-03 | 57 g in 1 TUBE (54766-716-03) | Pramosone Cream | Sebela Pharmaceuticals Inc. | 2015-08-04 |
| 54766-0716-04 | 28.4 g in 1 TUBE (54766-716-04) | Pramosone Cream | Sebela Pharmaceuticals Inc. | 2015-08-04 |
| 83107-0016-02 | 57 g in 1 TUBE (83107-016-02) | Pramosone Cream | Legacy Pharma USA Inc. | 2025-06-27 |
| 83107-0017-01 | 28.4 g in 1 TUBE (83107-017-01) | Pramosone Cream | Legacy Pharma USA Inc. | 2025-06-27 |
Observed labelers:
Legacy Pharma USA Inc. (2) ·
Sebela Pharmaceuticals Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.